Nursing practice questions with comprehensive rationales
NurseDive Free Nursing Practice Question
Which is Not a cause for hypervolemia?
A. Excessive fluid replacement
Excessive fluid replacement can lead to hypervolemia because it increases the total volume of fluid in the body. This can overwhelm the body's regulatory mechanisms, leading to fluid overload.
B. Dehydration
Dehydration is not a cause of hypervolemia. In fact, dehydration is the opposite condition, where there is a lack of fluid in the body. Dehydration leads to a decrease in fluid volume, not an increase.
C. Liver cirrhosis
Liver cirrhosis can cause hypervolemia because it impairs the liver's ability to regulate fluid balance. This can result in fluid retention and buildup in the body, leading to hypervolemia.
D. Kidney failure
Kidney failure can cause hypervolemia because the kidneys are responsible for maintaining fluid balance by excreting excess fluid. When the kidneys fail, they cannot effectively remove excess fluid, leading to fluid overload.
This question is an excerpt from Nurse Dive's nursing test bank - Ati pathophisiology proctored exam. Take the full exam now
Full Explanation
Choice A reason: Excessive fluid replacement can lead to hypervolemia because it increases the total volume of fluid in the body. This can overwhelm the body's regulatory mechanisms, leading to fluid overload.
Choice B reason: Dehydration is not a cause of hypervolemia. In fact, dehydration is the opposite condition, where there is a lack of fluid in the body. Dehydration leads to a decrease in fluid volume, not an increase.
Choice C reason: Liver cirrhosis can cause hypervolemia because it impairs the liver's ability to regulate fluid balance. This can result in fluid retention and buildup in the body, leading to hypervolemia.
Choice D reason: Kidney failure can cause hypervolemia because the kidneys are responsible for maintaining fluid balance by excreting excess fluid. When the kidneys fail, they cannot effectively remove excess fluid, leading to fluid overload.
Similar Questions
Obesity is a major risk factor for the development of type 2 diabetes. What is the mechanism for this?
A. Obesity is associated with hypercholesterolemia, which impairs the circulation of insulin.
While obesity can be associated with hypercholesterolemia, this condition primarily affects lipid levels and cardiovascular health rather than directly impairing insulin circulation.
B. Obesity is a result of high sugar intake, which leads to hyperglycemia.
Obesity is not solely a result of high sugar intake. While diet plays a role, obesity involves a complex interplay of genetic, environmental, and lifestyle factors. High sugar intake can contribute to weight gain, but it is not the direct cause of obesity.
C. Obesity releases fatty acids and cytokines, which interfere with insulin receptors.
Obesity releases fatty acids and cytokines, which interfere with insulin receptors. Adipose tissue in obese individuals releases pro-inflammatory cytokines and fatty acids that can cause insulin resistance by interfering with insulin signaling pathways.
D. Obesity is associated with a mutation of the MiR-21 gene, which is the same gene implicated in the development of insulin resistance.
Obesity is not directly associated with a mutation of the MiR-21 gene. While genetic factors can contribute to obesity and type 2 diabetes, the primary mechanism involves metabolic and inflammatory pathways rather than specific gene mutations.
Full Explanation
Choice A reason: While obesity can be associated with hypercholesterolemia, this condition primarily affects lipid levels and cardiovascular health rather than directly impairing insulin circulation.
Choice B reason: Obesity is not solely a result of high sugar intake. While diet plays a role, obesity involves a complex interplay of genetic, environmental, and lifestyle factors. High sugar intake can contribute to weight gain, but it is not the direct cause of obesity.
Choice C reason: Obesity releases fatty acids and cytokines, which interfere with insulin receptors. Adipose tissue in obese individuals releases pro-inflammatory cytokines and fatty acids that can cause insulin resistance by interfering with insulin signaling pathways.
Choice D reason: Obesity is not directly associated with a mutation of the MiR-21 gene. While genetic factors can contribute to obesity and type 2 diabetes, the primary mechanism involves metabolic and inflammatory pathways rather than specific gene mutations.
What would be the outcome if your patient did not have alpha cells of the pancreas?
A. They would not be able to secrete insulin.
Alpha cells of the pancreas do not produce insulin. Insulin is produced by the beta cells of the pancreas. Therefore, the absence of alpha cells would not affect insulin secretion.
B. They would not be able to secrete glucagon.
The primary function of alpha cells in the pancreas is to produce and secrete glucagon. Glucagon is a hormone that raises blood glucose levels by promoting the conversion of glycogen to glucose in the liver. Without alpha cells, the body would not be able to secrete glucagon, leading to issues with glucose regulation.
C. They would not be able to secrete somatostatin and gastrin.
Somatostatin and gastrin are not secreted by alpha cells. Somatostatin is produced by delta cells of the pancreas and other parts of the digestive system, while gastrin is primarily produced by G cells in the stomach lining. Therefore, the absence of alpha cells would not affect the secretion of somatostatin and gastrin.
D. They would not be able to secrete pancreatic polypeptides.
Pancreatic polypeptides are produced by PP cells (pancreatic polypeptide cells) in the pancreas. The absence of alpha cells would not impact the secretion of pancreatic polypeptides.
Full Explanation
Choice A reason: Alpha cells of the pancreas do not produce insulin. Insulin is produced by the beta cells of the pancreas. Therefore, the absence of alpha cells would not affect insulin secretion.
Choice B reason: The primary function of alpha cells in the pancreas is to produce and secrete glucagon. Glucagon is a hormone that raises blood glucose levels by promoting the conversion of glycogen to glucose in the liver. Without alpha cells, the body would not be able to secrete glucagon, leading to issues with glucose regulation.
Choice C reason: Somatostatin and gastrin are not secreted by alpha cells. Somatostatin is produced by delta cells of the pancreas and other parts of the digestive system, while gastrin is primarily produced by G cells in the stomach lining. Therefore, the absence of alpha cells would not affect the secretion of somatostatin and gastrin.
Choice D reason: Pancreatic polypeptides are produced by PP cells (pancreatic polypeptide cells) in the pancreas. The absence of alpha cells would not impact the secretion of pancreatic polypeptides.
The TNM (Tumor size, Node (lymph) & Metastases) classification is not used for brain tumors for:
A. Most patients with CNS tumors develop metastatic disease
Most patients with CNS tumors do not develop metastatic disease. Central nervous system (CNS) tumors, including brain tumors, typically do not metastasize outside the CNS. Instead, they grow and exert pressure on adjacent brain structures, leading to neurological symptoms.
B. Brain tumors are more deadly
While brain tumors can be very deadly, the TNM classification system is not avoided due to the lethality of the tumors. The main reason for not using the TNM system is because the classification criteria do not align well with the unique aspects of brain tumors.
C. Tumor size is less relevant than the location and histology
Tumor size is less relevant than the location and histology for brain tumors. The location of the tumor within the brain and its histological characteristics (e.g., type, grade, and molecular features) are more critical for prognosis and treatment planning. Brain tumors can cause significant clinical issues even when small, depending on their location.
D. Brain tumors have poor prognosis
Brain tumors can have a poor prognosis, but this is not the reason the TNM classification is not used. The classification system's limitation is primarily due to the fact that brain tumors' behavior and treatment considerations depend more on their location and histological features than on tumor size, nodal involvement, and metastasis, which are the focus of the TNM system.
Full Explanation
Choice A reason: Most patients with CNS tumors do not develop metastatic disease. Central nervous system (CNS) tumors, including brain tumors, typically do not metastasize outside the CNS. Instead, they grow and exert pressure on adjacent brain structures, leading to neurological symptoms.
Choice B reason: While brain tumors can be very deadly, the TNM classification system is not avoided due to the lethality of the tumors. The main reason for not using the TNM system is because the classification criteria do not align well with the unique aspects of brain tumors.
Choice C reason: Tumor size is less relevant than the location and histology for brain tumors. The location of the tumor within the brain and its histological characteristics (e.g., type, grade, and molecular features) are more critical for prognosis and treatment planning. Brain tumors can cause significant clinical issues even when small, depending on their location.
Choice D reason: Brain tumors can have a poor prognosis, but this is not the reason the TNM classification is not used. The classification system's limitation is primarily due to the fact that brain tumors' behavior and treatment considerations depend more on their location and histological features than on tumor size, nodal involvement, and metastasis, which are the focus of the TNM system.